Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine
US5900421A · kind A · utility
23Cited by
4References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 11, 1997 |
| Grant date | May 4, 1999 |
| Priority date | — |
| Expiry date | Feb 11, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods utilizing descarboethoxyloratadine ("DCL"), for the treatment of allergic disorders, while avoiding the concomitant liability of adverse side-effects associated with other non-sedating antihistamines. Also included are methods for the treatment of allergic asthma using DCL and either a decongestant or a leukotriene inhibitor, while avoiding the concomitant liability of adverse side-effects associated with other non-sedating antihistamines. The invention also encompasses the administration of DCL in a nasal or oral spray.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.